Relax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 3.00 M
as on 14-12-2024
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 51.38 Cr
as on 14-12-2024
- Satisfied Charges ₹ 23.10 Cr
as on 14-12-2024
- Revenue 97.26%
(FY 2022)
- Profit 220.14%
(FY 2022)
- Ebitda 234.78%
(FY 2022)
- Net Worth 26.27%
(FY 2022)
- Total Assets 84.67%
(FY 2022)
About Relax Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹51.38 Cr. The company has closed loans amounting to ₹23.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veer Pal, Bhupendra Kaushik, Abhay Srivastava, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231UP1997PTC022390
- Company No.
022390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1997
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Saharanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Relax Pharmaceuticals Private Limited offer?
Relax Pharmaceuticals Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Relax Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Srivastava  | Director | 01-Mar-2021 | Current |
| Veer Pal | Director | 31-Jul-1997 | Current |
| Bhupendra Kaushik | Director | 26-Mar-2021 | Current |
| Anju Jha | Director | 26-Mar-2021 | Current |
| Akhlas Ahmed | Director | 01-Mar-2021 | Current |
| Vikash Sharma | Whole-Time Director | 08-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Relax Pharmaceuticals.
Relax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 97.26% increase. The company also saw a substantial improvement in profitability, with a 220.14% increase in profit. The company's net worth Soared by an impressive increase of 26.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relax Pharmaceuticals?
In 2022, Relax Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sirmour Remedies Private LimitedActive 35 years 2 monthsAbhay Srivastava and Akhlas Ahmed are mutual person
Packtime Innovations Private LimitedActive 9 years 6 monthsAnju Jha and Akhlas Ahmed are mutual person
Copmed Pharmaceuticals Private LimitedActive 36 years 3 monthsVeer Pal, Bhupendra Kaushik and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Oct 2024 | ₹50.00 Cr | Open |
Others Creation Date: 17 Apr 2021 | ₹1.38 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Jul 2012 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Relax Pharmaceuticals?
Unlock and access historical data on people associated with Relax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
